6 sources checked · 2 source groups included · 1h ago
Still Watching
FDA approves landmark pancreatic cancer drug that's shown to improve survival
While all headlines celebrate the FDA's approval of a pancreatic cancer drug, some emphasize its "groundbreaking" or "transformative" potential more strongly.
2 Left4 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 26, 2026 at 6:00 PM, this is how Optics News reads the wording differences in this story.
What happenedThe FDA approved a groundbreaking new drug for the most common form of pancreatic cancer.
The headline splitThe left frames it as "F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer". The center frames it as "FDA approves landmark pancreatic cancer drug that’s shown to improve survival".
Match confidenceMedium confidence. 6 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
6 sources across 2 bias buckets agree on the event.
Framing confidenceMild
35/99 — small wording differences, not a major framing split.
WHAT EACH SIDE EMPHASIZED
Left / center-leftF.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
The New York Times · Center-left · News report
CenterFDA approves landmark pancreatic cancer drug that's shown to improve survival
WMUR9 (Hearst, Manchester NH) · Center · News report
Right / center-rightNo matching source in this bucket yet.
FDA approves groundbreaking new drug for pancreatic cancer
groundbreaking new
The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutati...
FDA approves groundbreaking new pancreatic cancer drug
groundbreaking new
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms...
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective tre...
